A 48-year-old woman sits forward on the stretcher, rubbing the same fingertip-sized spot beneath her left breast. The pain began while she was answering emails, feels sharp with a deep breath, and has already eased twice during the ride to the ED. She had a similar episode three weeks ago with a reassuring evaluation, but tonight her husband is watching the monitor more closely than she is. Her ECG and first high-sensitivity troponin are pending—the next decision has not yet been made.

— What’s your move? Read on.

Before you read
  • When can serial high-sensitivity troponin testing safely end the ED evaluation?
  • Which patients need outpatient follow-up, and which require observation or anatomic testing?

When to Think of It

Recurrent, brief, stable symptoms with a nonischemic history or clear alternative features; normal or unchanged ECG; no shock, heart failure, malignant arrhythmia, or ongoing severe pain. Enter ACS evaluation whenever symptoms are new, progressive, exertional, prolonged, associated with diaphoresis/dyspnea/syncope, or occurring in a high-risk patient—even if a prior workup was negative.

Sick or Not Sick

Sick vs. not sick: Is there ongoing ischemia or instability? The pivotal call is whether this is possible ACS requiring expedited serial evaluation/admission, versus stable low-risk chest pain eligible for an accelerated discharge pathway. Use clinical assessment plus ECG and a validated pathway such as HEART/EDACS; do not use a score as a substitute for judgment.

The First Fifteen Minutes

  • Obtain immediate ECG and repeat it for persistent or changing pain; place on monitoring, establish IV access, and assess for alternate catastrophes.
  • If ACS remains plausible and there is no active bleeding or true aspirin allergy → aspirin 324 mg PO, chewed once, because rapid platelet inhibition reduces coronary thrombus propagation.
  • If ongoing suspected ischemic pain with SBP ≥90 mm Hg, no right-ventricular infarction, severe aortic stenosis, or PDE-5 inhibitor exposure → nitroglycerin 0.4 mg SL every 5 minutes for up to 3 doses, because venodilation lowers preload and myocardial oxygen demand. Do not use it to “treat” nonspecific low-risk pain automatically.
  • Obtain hs-cTn according to the assay-specific 0/1-hour or 0/2-hour protocol; interpret delta values with the assay’s validated thresholds, not a generic cutoff.
  • If hypotension, hypoxemia, pulmonary edema, or aortic-dissection features appear, abandon the low-risk pathway and resuscitate/evaluate for the alternate emergency.

Definitive Care & Disposition

A nonischemic ECG plus serial hs-cTn values meeting a validated rule-out pathway and a compatible history supports discharge without routine stress testing or CCTA. Arrange primary-care/cardiology follow-up for persistent or exertional symptoms and address smoking, blood pressure, diabetes, and lipids. Observation, CCTA, stress imaging, or admission is appropriate for intermediate risk, equivocal troponin change, new ECG abnormality, unreliable follow-up, or recurrent symptoms with a different pattern. Confirm that prior “negative” testing was adequate and recent enough to be relevant; a prior normal test does not neutralize new symptoms.

How This One Kills

The dangerous error is treating a prior negative workup as a permanent diagnosis of “noncardiac pain,” then missing a new ACS because the patient’s recurrent symptoms are now exertional, prolonged, or associated with dynamic ECG/troponin changes.
The Differential — What Else Looks Like This
  • Pulmonary embolism — pleuritic pain, tachycardia, hypoxemia, or risk factors; missing it while applying a coronary-only pathway can be fatal.
  • Aortic dissection — abrupt maximal pain, pulse/BP differential, neurologic deficit, or mediastinal widening; antithrombotic treatment can worsen bleeding.
  • Pericarditis — positional/pleuritic pain with diffuse ST elevation or PR depression; a focal coronary interpretation can miss effusion or myocarditis.
  • Esophageal or chest-wall pain — reproducible or meal-related symptoms; falsely labeling all recurrent pain benign can still miss a changing ACS pattern.

The Second-Day Story

Older adults, women, and patients with diabetes or chronic kidney disease may report dyspnea, fatigue, nausea, back discomfort, or vague pressure rather than pain. Prior negative testing and symptom-free intervals further degrade the signal. Reconstruct the current episode carefully—onset, exertional relationship, duration, progression, associated symptoms—and let the ECG, serial hs-cTn delta, physiology, and risk context determine the pathway.
Back to Our Patient
Back to the 48-year-old woman with the fingertip-sized pleuritic pain: she is not sick—normal vital signs, no heart failure, no syncope, and a nonischemic ECG—and her pain is neither exertional nor progressive. Serial hs-cTn values remain below the assay pathway’s rule-out thresholds without a significant delta, so she meets a validated low-risk discharge pathway rather than an automatic admission; aspirin and nitroglycerin are not required for her resolved, nonischemic symptoms. She leaves with explicit return precautions for exertional/prolonged pain, dyspnea, syncope, or diaphoresis and timely outpatient follow-up.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a 48-year-old woman with recurrent, brief, sharp left parasternal chest pain that began at rest while emailing and is worse with deep inspiration. She had a similar reassuring evaluation three weeks ago, and tonight she has no exertional component, dyspnea, diaphoresis, syncope, fever, hemoptysis, unilateral leg swelling, or tearing radiation. She is hemodynamically stable, comfortable, has clear lungs, no edema, and no focal chest-wall or neurologic findings. Her ECG is nonischemic, and serial high-sensitivity troponins are negative without a significant delta. I assess her as low-risk recurrent nonischemic chest pain with ACS and other immediate threats unlikely, and I plan discharge with return precautions and outpatient follow-up.”

Study Directive

  • Draw the HEART and EDACS variables from memory and identify which elements are subjective.
  • Review your local hs-cTn 0/1-hour or 0/2-hour algorithm and memorize its rule-out, observation, and rule-in thresholds.
  • Practice three cases: recurrent pleuritic pain, recurrent exertional pain, and recurrent pain with a small troponin delta; commit to discharge, observation, or admission before seeing the answer.
  • Audit five recent chest-pain charts for documentation of ECG timing, serial troponin interpretation, alternative diagnoses, and follow-up.